Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? (Q37815613)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? |
scientific article |
Statements
1 reference
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? (English)
1 reference
Viviana Bazan
1 reference
Nicola Silvestris
1 reference
Sergio Rizzo
1 reference
Giuseppe Bronte
1 reference
Lidia Corsini
1 reference
Nicola Gebbia
1 reference
Fabio Fulfaro
1 reference
Antonio Russo
1 reference
1 November 2010
1 reference
1 reference
Identifiers
1 reference